1062082-72-7Relevant academic research and scientific papers
Diarylheptanoid compound
-
Paragraph 0066; 0071; 0079, (2017/07/21)
The invention discloses a diarylheptanoid compound shown as a formula (A). The compound provided by the invention can be used for remarkably inhibiting transcription and protein expression of iNOS, IL-1beta and IL-6 and a phosphorylation level of IkappaB protein, and can be used for treating inflammation and other various diseases including ichorrhemia and Alzheimer disease. (The formula (A) is shown in the description.).
